The introduction of nicotinamide for a nicotine alternative in e-cigarette and smokeless items represents a substantial regulatory challenge for that FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is known to act as a sedative at large dosages6. The claims produced by Nicotine River, ECBlend, along with other vendors that th